Clinical Studies and Trials for Eosinophilic Disorders
We are actively conducting research to help understand and improve outcomes for patients with eosinophilic disorders. For more information on our ongoing clinical research, open the descriptions of our clinical studies and trials below.
For research inquiries, contact the Cincinnati Center for Eosinophilic Disorders (CCED) at ccedresearch@cchmc.org.
For more of our clinical trials, visit these clinicaltrials.gov webpages:
- Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING)
- A Study of CDX-0159 in Patients With Eosinophilic Esophagitis (EvolvE)
- Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial (DESTINY)
- A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis (ENGAGE)
- Zemaira Eosinophilic Esophagitis Pilot Study (ZEEPS)